SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001654954-20-001247
Filing Date
2020-02-07
Accepted
2020-02-07 17:15:54
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM S-3 azrxs3_feb2020.htm S-3 928241
2 CONSENTS OF EXPERTS AND COUNSEL ex23-2.htm EX-23.2 4951
3 IMAGE azrxs3_feb2020000.jpg GRAPHIC 3032
4 IMAGE azrxs3_feb2020001.jpg GRAPHIC 3929
  Complete submission text file 0001654954-20-001247.txt   944168
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-236333 | Film No.: 20588413
SIC: 2834 Pharmaceutical Preparations